![]() Lagevrio works by interfering with the replication of the Covid-19 virus, preventing it from multiplying. These risk factors include obesity, older age (over 60), diabetes or heart disease. On Novemthe Medicines and Healthcare products regulatory agency (MHRA) announced that it was safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate Covid-19 who are at increased risk of developing severe disease. Molnupiravir (brand name Lagevrio) is the first antiviral Covid-19 treatment which can be taken as a tablet. It's a "broad-spectrum" antiviral, which means that it works against a range of viruses. The main candidates are: Molnupiravir - a broad spectrum anti-viral One potential approach is to use medications which may be able to directly block the ability of the coronavirus to infect and reproduce itself within the body. I’d like to sign-up Anti-viral medications Our fortnightly Heart Matters newsletter includes the latest updates about coronavirus when you have a heart condition, as well as support for healthy eating, staying active and your emotional wellbeing. We’re here for you with information and support around coronavirus
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |